Interchangeable products are generic drugs which must be the bioequivalent of the comparator brand, contain the same amount(s) of the same active ingredient(s), and have the same route(s) of administration. They must conform to official Canadian standards and are under continuous review.
The determination of "interchangeability" among pharmaceutical products which are sold in Nova Scotia by more than one manufacturer is solely the responsibility of the Department of Health and Wellness.
A list of newly approved interchangeable products for the Pharmacare Programs along with details on their benefit status is posted here on a monthly basis. The list is posted by the first Wednesday of each month with interchangeability status taking effect the following Monday.
If you require access to updates that were published prior to January 2012, please send a detailed request to the Nova Scotia Pharmacare Programs at firstname.lastname@example.org